Cadherin-11 Deficiency Attenuates Ang-II-Induced Atrial Fibrosis and Susceptibility to Atrial Fibrillation

References

• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–847. doi:10.1161/CIRCULATIONAHA.113.005119
   PubMed Web of Science ®Google Scholar
• Chao TF, Lip GYH, Liu CJ, et al. Relationship of aging and incident comorbidities to stroke risk in patients with atrial fibrillation. J Am Coll Cardiol. 2018;71(2):122–132. doi:10.1016/j.jacc.2017.10.085
   PubMed Web of Science ®Google Scholar
• Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63(22):2335–2345. doi:10.1016/j.jacc.2014.02.555
   PubMedGoogle Scholar
• Jalife J, Kaur K. Atrial remodeling, fibrosis, and atrial fibrillation. Trends Cardiovasc Med. 2015;25(6):475–484. doi:10.1016/j.tcm.2014.12.015
   PubMed Web of Science ®Google Scholar
• Leask A. Potential therapeutic targets for cardiac fibrosis: tGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res. 2010;106(11):1675–1680. doi:10.1161/CIRCRESAHA.110.217737
   PubMed Web of Science ®Google Scholar
• He X, Gao X, Peng L, et al. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ Res. 2011;108(2):164–175. doi:10.1161/CIRCRESAHA.110.234369
   PubMed Web of Science ®Google Scholar
• Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation. 2011;124(20):2264–2274. doi:10.1161/CIRCULATIONAHA.111.019893
   PubMed Web of Science ®Google Scholar
• Yue L, Xie J, Nattel S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res. 2011;89(4):744–753. doi:10.1093/cvr/cvq329
   PubMed Web of Science ®Google Scholar
• Wheelock MJ, Johnson KR. Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol. 2003;19:207–235. doi:10.1146/annurev.cellbio.19.011102.111135
   PubMed Web of Science ®Google Scholar
• Huang CF, Lira C, Chu K, et al. Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. Cancer Res. 2010;70(11):4580–4589. doi:10.1158/0008-5472.CAN-09-3016
   PubMed Web of Science ®Google Scholar
• Lodyga M, Cambridge E, Karvonen HM, et al. Cadherin-11-mediated adhesion of macrophages to myofibroblasts establishes a profibrotic niche of active TGF-β. Sci Signal. 2019;12:564. doi:10.1126/scisignal.aao3469
   Web of Science ®Google Scholar
• Alimperti S, You H, George T, Agarwal SK, Andreadis ST. Cadherin-11 regulates both mesenchymal stem cell differentiation into smooth muscle cells and the development of contractile function in vivo. J Cell Sci. 2014;127(Pt 12):2627–2638. doi:10.1242/jcs.134833
   PubMed Web of Science ®Google Scholar
• Schneider DJ, Wu M, Le TT, et al. Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-β production and epithelial to mesenchymal transition. FASEB j. 2012;26(2):503–512.
   PubMed Web of Science ®Google Scholar
• Wu M, Pedroza M, Lafyatis R, et al. Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis. Arthritis Rheumatol. 2014;66(4):1010–1021. doi:10.1002/art.38275
   PubMed Web of Science ®Google Scholar
• Bowler MA, Bersi MR, Ryzhova LM, Jerrell RJ, Parekh A, Merryman WD. Cadherin-11 as a regulator of valve myofibroblast mechanobiology. Am J Physiol Heart Circ Physiol. 2018;315(6):H1614–h1626. doi:10.1152/ajpheart.00277.2018
   PubMed Web of Science ®Google Scholar
• Fang G, Cao W, Chen L, et al. Cadherin-11 deficiency mitigates high-fat diet-induced inflammatory atrial remodeling and vulnerability to atrial fibrillation. J Cell Physiol. 2021;236(8):5725–5741. doi:10.1002/jcp.30257
   PubMed Web of Science ®Google Scholar
• Wang Q, Yu Y, Zhang P, et al. The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation. Basic Res Cardiol. 2017;112(4):47. doi:10.1007/s00395-017-0634-1
   PubMed Web of Science ®Google Scholar
• Song S, Liu L, Yu Y, et al. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis. J Mol Cell Cardiol. 2019;127:83–96. doi:10.1016/j.yjmcc.2018.12.002
   PubMed Web of Science ®Google Scholar
• Monahan TS, Andersen ND, Panossian H, et al. A novel function for cadherin 11/osteoblast-cadherin in vascular smooth muscle cells: modulation of cell migration and proliferation. J Vasc Surg. 2007;45(3):581–589. doi:10.1016/j.jvs.2006.12.016
   PubMed Web of Science ®Google Scholar
• Song S, Zhang R, Mo B, et al. EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation. J Mol Cell Cardiol. 2019;135:119–133. doi:10.1016/j.yjmcc.2019.08.003
   PubMed Web of Science ®Google Scholar
• Yao C, Veleva T, Scott L Jr, et al. Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation. Circulation. 2018;138(20):2227–2242. doi:10.1161/CIRCULATIONAHA.118.035202
   PubMed Web of Science ®Google Scholar
• Wang Q, Chen Y, Zhang D, et al. Activin Receptor-Like Kinase 4 haplodeficiency mitigates arrhythmogenic atrial remodeling and vulnerability to atrial fibrillation in cardiac pathological hypertrophy. J Am Heart Assoc. 2018;7(16):e008842. doi:10.1161/JAHA.118.008842
   PubMed Web of Science ®Google Scholar
• Titus VH, Cowling RT, Kailasam S. Collagen receptor cross-talk determines α-smooth muscle actin-dependent collagen gene expression in angiotensin II-stimulated cardiac fibroblasts. J Biol Chem. 2019;294(51):19723–19739. doi:10.1074/jbc.RA119.009744
   PubMed Web of Science ®Google Scholar
• Frangogiannis N. Transforming growth factor-β in tissue fibrosis. J Exp Med. 2020;217(3):e20190103. doi:10.1084/jem.20190103
   PubMed Web of Science ®Google Scholar
• Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986;83(12):4167–4171. doi:10.1073/pnas.83.12.4167
   PubMed Web of Science ®Google Scholar
• Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425(6958):577–584. doi:10.1038/nature02006
   PubMed Web of Science ®Google Scholar
• Medici D, Potenta S, Kalluri R. Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochem J. 2011;437(3):515–520. doi:10.1042/BJ20101500
   PubMedGoogle Scholar
• Madarampalli B, Watts GFM, Panipinto PM, Nguygen HN, Brenner MB, Noss EH. Interactions between cadherin-11 and platelet-derived growth factor receptor-alpha signaling link cell adhesion and proliferation. Biochim Biophys Acta Mol Basis Dis. 2019;1865(6):1516–1524. doi:10.1016/j.bbadis.2019.03.001
   PubMed Web of Science ®Google Scholar
• Mizoguchi F, Slowikowski K, Wei K, et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat Commun. 2018;9(1):789. doi:10.1038/s41467-018-02892-y
   PubMed Web of Science ®Google Scholar
• Chen PF, Wang F, Nie JY, et al. Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer. Onco Targets Ther. 2018;11:6425–6436. doi:10.2147/OTT.S176511
   PubMed Web of Science ®Google Scholar
• Chang SK, Kohlgruber AC, Mizoguchi F, et al. Stromal cell cadherin-11 regulates adipose tissue inflammation and diabetes. J Clin Invest. 2017;127(9):3300–3312. doi:10.1172/JCI86881
   PubMed Web of Science ®Google Scholar
• Chang SK, Noss EH, Chen M, et al. Cadherin-11 regulates fibroblast inflammation. Proc Natl Acad Sci U S A. 2011;108(20):8402–8407. doi:10.1073/pnas.1019437108
   PubMed Web of Science ®Google Scholar
• Blaue C, Kashef J, Franz CM. Cadherin-11 promotes neural crest cell spreading by reducing intracellular tension-Mapping adhesion and mechanics in neural crest explants by atomic force microscopy. Semin Cell Dev Biol. 2018;73:95–106. doi:10.1016/j.semcdb.2017.08.058
   PubMed Web of Science ®Google Scholar
• Pittet P, Lee K, Kulik AJ, Meister JJ, Hinz B. Fibrogenic fibroblasts increase intercellular adhesion strength by reinforcing individual OB-cadherin bonds. J Cell Sci. 2008;121(Pt 6):877–886. doi:10.1242/jcs.024877
   PubMed Web of Science ®Google Scholar
• To S, Agarwal SK. Macrophages and cadherins in fibrosis and systemic sclerosis. Curr Opin Rheumatol. 2019;31(6):582–588. doi:10.1097/BOR.0000000000000657
   PubMed Web of Science ®Google Scholar
• Merryman WD, Clark CR. Lnc-ing NOTCH1 to idiopathic calcific aortic valve disease. Circulation. 2016;134(23):1863–1865. doi:10.1161/CIRCULATIONAHA.116.025601
   PubMed Web of Science ®Google Scholar
• Clark CR, Bowler MA, Snider JC, Merryman WD. Targeting Cadherin-11 prevents notch1-mediated calcific aortic valve disease. Circulation. 2017;135(24):2448–2450. doi:10.1161/CIRCULATIONAHA.117.027771
   PubMed Web of Science ®Google Scholar
• Schroer AK, Bersi MR, Clark CR, Zhang Q, Merryman WD Cadherin-11 blockade reduces inflammation-driven fibrotic remodeling and improves outcomes after myocardial infarction. 2019.
   Google Scholar
• Brittany B, Hao, et al. Collectivization of vascular smooth muscle cells via TGF-β-Cadherin-11-Dependent Adhesive Switching. Arterioscler Thromb Vasc Biol. 2015.
   Web of Science ®Google Scholar
• Balint B, Yin H, Chakrabarti S, Chu MW, Sims SM, Pickering JG. Collectivization of vascular smooth muscle cells via TGF-β-Cadherin-11-dependent adhesive switching. Arterioscler Thromb Vasc Biol. 2015;35(5):1254–1264. doi:10.1161/ATVBAHA.115.305310
   PubMed Web of Science ®Google Scholar